AMEDISYS, INC. (NASDAQ:AMED) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
On February27, 2018, Amedisys, Inc. (“we,” “us,” “our” or the “Company”) issued a press release announcing our financial results for the fourth quarter and year ended December31, 2017. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information presented in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless we specifically state that the information is to be considered “filed” under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.
SECTION 5 — CORPORATE GOVERNANCE AND MANAGEMENT
| Item 2.02. | DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS |
On February21, 2018, Amedisys, Inc. (the “Company”) and Stephen Seim, the Company’s Chief Strategy Officer, mutually agreed that Mr. Seim will be leaving the Company, effective March5, 2018. Mr.Seim’s departure will constitute a termination without cause.
SECTION7 – REGULATION FD
| Item 2.02. | REGULATION FD DISCLOSURE |
Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.
In addition, a copy of the supplemental slides which will be discussed during the Company’s earnings call at 12:00 p.m. ET on Wednesday, February28, 2018 is attached to this report as Exhibit 99.2 and incorporated herein by reference.
The information presented in Item 2.02 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section18 of the Exchange Act, or otherwise subject to the liabilities of that section, unless we specifically state that the information is to be considered “filed” under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act or the Exchange Act.
SECTION9 – FINANCIAL STATEMENTS AND EXHIBITS
| Item 2.02. | FINANCIAL STATEMENTS AND EXHIBITS |
(d) Exhibits.
AMEDISYS INC ExhibitEX-99.1 2 d538219dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 AMEDISYS REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS ISSUES 2018 GUIDANCE BATON ROUGE,…To view the full exhibit click here
About AMEDISYS, INC. (NASDAQ:AMED)
Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company’s personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.
